Introduction
The European Parliament [1] and the Parliamentary Assembly of the Council of Europe [2] have both passed resolutions recommending a stronger harmonization of, what they call, non-conventional medicine in Europe.
The European Union (EU) has, however, repeatedly confirmed that it is up to each member state to organize and regulate their healthcare system, and this will, of course, also apply to complementary and alternative medicine (CAM). Despite this confirmation, the recent Patients' Rights in Cross-Border Healthcare Directive 2011/24/EU [3] and other directives indirectly encourage some degree of harmonization. CAM professions can be registered in the European Commission (EC) database of regulated professions, and patients will probably have certain rights according to the Cross-Border Healthcare Directive. The EU has also passed directives regulating medicinal products that also cover CAM medicinal products [4] [5] [6] .
Wiesener/Falkenberg/Hegyi/Hök/ Roberti di Sarsina/Fønnebø This report covers 27 EU member states as well as 12 associated states. Each state is influenced by the EU legislation and has adjusted their national legislation depending on their connection to EU. The countries' status in relation to the EU is shown in figure 1 .
Results

Country-Specific Regulations
CAM treatment is in general either unregulated or regulated within the framework of the public health system. The only common factor that we have found across all 39 nations is the amazing ability they have demonstrated for structuring legislation and regulation differently in every single country, no matter how small the size of the population.
Of the 39 countries, 17 have a general CAM legislation, 11 of these 17 have a specific CAM law and 6 countries have sections on CAM included in their health laws (like 'law on healthcare' or 'law on health professionals'). In addition to the general CAM legislation, some countries have regulations on specific CAM treatments ( fig. 2) .
The CAM regulations are either very general or very detailed, and we found no more similarities between the countries that have a CAM law or general CAM legislation than between the countries with only specific CAM treatment regulations. Some of the general regulations are only a specification of what CAM is, often to be supported by additional regulations or specifications issued by the Ministry of Health or the professions' associations. In some countries additional specifications have not been made. As an example, both Norway and Hungary have a CAM law. In Norway the CAM law is general without describing in detail the treatments or practitioners, in Hungary CAM can be regarded as an integral aspect of the healthcare system. We found few similarities in the regulations of the specific CAM treatments between the countries, and it is challenging to find out who is allowed to practice the different treatments.
The 12 common treatment modalities vary considerably with regard to how many countries regulate the profession or practice in some way or another. Acupuncture is regulated in Previous studies on the European situation with regard to how CAM is regulated [7] [8] [9] have shown a diverse pattern. Reports from key CAM stakeholders have indicated that the regulatory situation has changed, and the CAMbrella consortium has therefore seen it as important to establish the current status in order to best prepare a roadmap for CAM research in Europe. ᭺ The extent of country-specific market authorization of herbal and homeopathic medicinal products according to the EU directives. 4 Review at EU level:
᭺ The status of EU-wide regulation of CAM practices. ᭺ The potential obstacles for EU-wide regulation of CAM practices.
Methods
As an introduction we made a comprehensive overview of matters that may influence CAM in the European legislation. Descriptions of health issues, the legal and CAM terminology, and the interaction between conventional medicine and CAM vary both in the EU bodies and within the 39 countries included in this report. To address CAM-related legislation in the EU, we included both the EU legislation that influences the member states' national health legislation and various aspects of EU regulation of conventional medicine. Data underlying this report were collected from the 39 countries by communicating with the Ministries of Health, Law or Education, governmental representatives, and members of national CAM associations. A search was also performed in the national websites/databases to identify official law documents. The scientific and non-scientific literature was also searched for documents and websites describing CAM regulation in each of the 39 countries. We also collected information from European CAM associations/coalitions, CAMbrella members, and stakeholders. Personal visits, including meetings with the ministries of health and CAM practitioners representing organizations, were made to 4 countries. Health authorities (if possible both legal and regulatory) were asked to verify the situation described for their specific country. 12 common treatment modalities have been described in detail in each country. In addition, a search was performed in the EUROPA and EUR-lex websites/databases to identify official EU law documents. We searched specifically for information about EU directives regarding European-wide healthcare-related regulation, as well as regulation of herbal and homeopathic medicinal products and their EU/EFTA/EEA implications.
A personal visit was also made to the EU offices and non-government organization (NGO) bodies in Brussels to establish firsthand updated information. Meetings were held with:
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Legal Status and Regulation of CAM in Europe 31 sence of regulation) was too unclear for us to be certain, we have inserted a question mark. Since the countries with CAM practitioners like 'Heilpraktiker', 'healer' and likewise may not be correctly represented, we decided not to introduce this table for other treatments because of the unclear situation.
Medicinal Products
Medicinal products are not defined as a part of health policy, and can therefore be regulated at the EU level. The individual states within the EU/EEA area are therefore no longer free to uphold a national regulation of medicinal products in violation of the following 3 EU directives. . Now that this 27 countries, anthroposophic medicine in 8 countries, Ayurveda in 5 countries, chiropractic in 27 countries, herbal medicine/phytotherapy in 11 countries, homeopathy in 25 countries, massage in 20 countries, naprapathy (manual therapy) in 2 countries, naturopathy in 9 countries, neural therapy in 3 countries, osteopathy in 16 countries, and finally Traditional Chinese Medicine in 10 countries.
As an example, figure 3 shows the regulation of homeopathy across Europe. Switzerland has regulated homeopathy and has registered homeopath as a profession in the EU regulated professions database under 'natural health practitioner' as 'naturopath/homeopath'. 2 countries (Latvia, Liechtenstein) have regulations that may be seen as a regulation of a homeopathy profession. Latvia has regulated 'homeopathic doctors', Liechtenstein has registered 'natural health practitioner with a homeopathy specialty'. 22 countries have regulated homeopathy treatment. 14 countries have no specific homeopathic treatment regulations, but general CAM or other health legislation may regulate homeopathic practices. Figure 4 'Homeopathy -Who may practise' is an example of how difficult it can be to understand the consequences of national regulation. We have, to our best knowledge, listed whether the different categories of practitioners in each country are allowed to practice homeopathy. If only medical doctors with additional CAM education are allowed to practice, we have put 'No' in the column for medical doctors. The same applies for other health personnel. If the regulation (or ab- Wiesener/Falkenberg/Hegyi/Hök/ Roberti di Sarsina/Fønnebø same application procedures as other medicinal products regarding manufacturing procedures, technical quality of the product, and all other requirements, with the possible exception of documentation of efficacy. There are 4 administrative procedures that can be followed to obtain a market authorization for these products (standard, well-established use, and 2 simplified registration procedures (one for homeopathic medicinal products and the other for traditional-use registration of herbal medicinal products)). The simplified registration procedures allow alternative documentation of efficacy.
Homeopathic medicinal products covered by a registration or authorization granted in accordance with national legislation on or before December 31, 1993 and herbal medicinal products already authorized in accordance with regulation (EEC) No. 2309/93 [10] or supplied in response to a bona fide unsolicited order can be marketed irrespective of the 2 directives. These uniform regulations aim to supply citizens with a predictable standard of all medicinal products (including herbal and homeopathic) across Europe. Several stakeholders raised concerns before the rules were implemented. The concerns focused mainly on leaving European citizens without access to beneficial products and the establishment of unnecessary additional authorizational bureaucracy around safe products.
EU-Wide Regulation
The directives, regulations and resolutions in the EU and the Council of Europe that may influence the professional practice of CAM, whether practiced by an authorized/licensed healthcare provider or by a provider without such authorization/licensing, will also affect the conditions under which patients can receive CAM treatment(s) in Europe.
We have found no direct EU legislation of CAM except for directives concerning CAM medicinal products described above. 2 resolutions deal with non-conventional medicine:
᭺ Resolution A4-0075/97: 'Resolution on the status of nonconventional medicine'. This is part of the European Parliament resolution on how non-conventional medicine should be included more formally as a special field in the European legislation [1] .
᭺ Resolution 1206 (1999): 'A European approach to nonconventional medicines' of the Parliamentary Assembly of the Council of Europe resolution on non-conventional medicine [2] . How legislation connected to 'The 4 Freedoms' is handled in EU/EEA, influences the national CAM legislation and legislation that impacts directly or indirectly on CAM of the individual states. Of particular interest is how patients and health professionals are able to relate to diverse national CAM regulations. European CAM practitioners have different levels of training as a basis for their practice, whether they are formally licensed or not, and patients have varying expectations depending on experiences from their home country.
Harmonization of training and regulation of non-conventional disciplines is only marginally covered in the directive 2005/36/EC Professional Qualifications [11] . In many states only doctors or other health professionals are allowed to practice CAM according to national health regulation. The EUregulated professionals database includes only a few CAM professions in some member states. We have found that the resolutions on the status of non-conventional medicine from 1997 and 1999 have not been followed up with harmonized CAM training or regulation.
Discussion
Our findings demonstrate an extraordinary diversity with regard to the regulation of CAM practice across Europe. At the same time the medicinal products that CAM practitioners will be prescribing or recommending are regulated uniformly across the same geographical area. This regulatory diversity will profoundly influence patients, practitioners and researchers when crossing European borders.
When patients cross borders in search of CAM treatment, they may encounter substantial differences in the professional background of apparently identical CAM providers who are mostly also working under completely different reimbursement systems. In post-modern Europe, where patient choice in healthcare is seen as a core value [12], this confusing European market makes any informed treatment-seeking challenging. This heterogeneous situation influences CAM patients' rights, access and potential safety, and constitutes a challenge to a harmonized national and European follow-up of the new Patients' Rights in Cross-Border Healthcare Directive 2011/24/EU [3].
When practitioners cross borders they will encounter a substantial variety of CAM practice in Europe. This raises serious concerns with regard to the predictability, quality and safety of healthcare delivery to European citizens. When CAM professions in some countries are tightly regulated, while the same professional categories in other countries are totally unregulated, establishing a common collegial ground is very challenging.
When researchers cross borders they will find that research on efficacy and effectiveness of CAM is severely hampered by the conglomerate of European regulation. Practices and practitioners are not comparable across national boundaries, and any observational or experimental study will therefore be generalizable only within a narrow national or cultural context.
The European Parliament resolution on non-conventional medicine from 1997 [1] stated that non-conventional medical disciplines should be clearly identified and defined. We have found few overall clear distinctions between conventional and non-conventional medicine in the EU legislation. therapies will require special knowledge in the CAM field to take into account the special features of this field of healthcare. Developing the European legislation of CAM by simply adapting the criteria of conventional medicine will probably be inadequate for regulation of the CAM field. Similar to the way that CAM research needs some particular considerations compared to research on, e.g., conventional pharmaceuticals [13] , the methods by which CAM is regulated must be specifically tailored to its inherent qualities. In particular, the Patients' Rights in Cross-Border Healthcare Directive [3] respects the established differences in national healthcare systems. It aims to remove obstacles to the fundamental freedoms that enable patients from one EU member state to choose to seek treatment in another EU member state. The directive also outlines the responsibilities of EU member state healthcare systems to cover treatments given in other member states. Regional collaboration between providers, purchasers, and regulators from the different member states can ensure safe, high-quality, and efficient cross-Border healthcare at a regional level. Historical and cultural similarities between neighbouring countries would thus seem to potentially facilitate cross-border opportunities in the CAM area more than EU-wide directives, regulations and decisions.
The most important obstacles that hinder the European Parliament resolution call for 'a process of recognizing nonconventional medicine are the Treaties of Rome and Lisbon [14] , which clearly state that the individual member states have the responsibility for 'the definition of their health policy and for the organization and delivery of health services and medical care. The responsibilities of the member states shall include the management of health services and medical care and the allocation of the resources assigned to them. This legitimizes and sustains the wide variations in CAM regulation across Europe.
Another obstacle is the unwillingness of the individual European countries to voluntarily harmonize their legislation and regulation of CAM with other European states. If this had been done to a greater degree, both patients and providers would be able to benefit from The Right to Move and Reside Freely Directive [15] , the Professional Qualifications Directive [11] , the Patients' Rights in Cross-Border Healthcare Directive [3], the Services Directive [16] , and the Social Security Regulation [17] .
There are in principle, therefore, 2 options that can be chosen to achieve a higher degree of harmonization: legislation and regulation at the EU/EEA level or voluntary harmonization. We do not foresee EU/EEA level legislation/regulation in the foreseeable future since the EU has repeatedly upheld its position of leaving this to the individual country. Voluntary harmonization is, however, possible within current legislation. We think it is important to encourage individual states within culturally similar regions to harmonize their CAM legislation and regulation. This broader regional perspective can probably safeguard against inadequately justified over-or underregulation at the local level. The successful mutual recognition of physiotherapists across Europe shows how this can be done. Physiotherapy has a long tradition of being a recognized profession with well-established international research on the importance and effect of physiotherapy treatment. The European collaboration within the World Confederation for Physical Therapy Europe (WCPT-E) and the European Network of Physiotherapy in Higher Education (ENPHE) leads to exchange of experience and harmonized regulation, education and professional issues within the EU and the European countries. This could be a potential template for development of harmonized regulation of CAM professions in Europe [18] .
